NCT03379857View on ClinicalTrials.gov

Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke

NAActive, not recruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 11, 2018

Primary Completion Date

January 11, 2025

Study Completion Date

January 11, 2025

Conditions

StrokeCannabis Use

Interventions

OTHER

Drug urinal test

Non Applicable

Trial Locations (6)

21079

Chu Bocage, Dijon

25030

Chu Jean Minjoz, Besançon

54035

Hopital Central, Nancy

67098

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

68024

Unite Neuro-Vasculaire, Colmar

68070

C.H. G. Muller, Mulhouse

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER

NCT03379857 - Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke | Biotech Hunter | Biotech Hunter